Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBiogen Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 28 | $1.50 | $4.84 | $3.05 |
| Q2 2026 | 20 | -$50.01 | $9.98 | $2.94 |
| Q3 2026 | 20 | $1.19 | $2.99 | $2.03 |
| Q4 2026 | 20 | $2.78 | $3.90 | $3.28 |
| Q1 2027 | 9 | $3.38 | $3.84 | $3.65 |
| Q2 2027 | 9 | $3.94 | $4.48 | $4.26 |
| Q3 2027 | 9 | $3.95 | $4.49 | $4.27 |
| Q4 2027 | 9 | $4.09 | $4.64 | $4.42 |
| Q1 2028 | 10 | $5.07 | $5.75 | $5.47 |
| Q2 2028 | 10 | $5.52 | $6.27 | $5.96 |
| Q3 2028 | 10 | $5.00 | $5.67 | $5.40 |
| Q4 2028 | 10 | $5.04 | $5.72 | $5.45 |
Biogen Inc Earnings Date And Information
Biogen Inc last posted its earnings results on Wednesday, July 29th, 2026. The company reported $3.6 earnings per share for the quarter, topping analysts' consensus estimates of $2.94 by $0.66. The company had revenue of 2.74 B for the quarter and had revenue of 9.81 B for the year. Biogen Inc has generated $9 earnings per share over the last year ($8.83 diluted earnings per share) and currently has a price-to-earnings ratio of 38.17. Biogen Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Biogen Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 07/29/2026 | Q2 2026 | $2.94 | $0.66 | -2.28 | $2.46 B | $2.74 B |
| 04/29/2026 | Q1 2026 | $3.05 | $2.17 | -0.88 | $2.29 B | $2.48 B |
| 02/06/2026 | Q4 2025 | $1.63 | -$0.33 | -1.96 | $2.20 B | $2.28 B |
| 10/30/2025 | Q3 2025 | $3.88 | $3.18 | -0.7 | $2.34 B | $2.45 B |
| 07/31/2025 | Q2 2025 | $3.90 | $4.35 | 0.45 | $2.33 B | $2.65 B |
| 05/01/2025 | Q1 2025 | $2.90 | $1.65 | -1.25 | $2.23 B | $2.43 B |
| 02/12/2025 | Q4 2024 | $3.43 | $1.83 | -1.6 | $2.41 B | $2.45 B |
| 10/30/2024 | Q3 2024 | $3.77 | $2.67 | -1.1 | $2.43 B | $2.47 B |
| 08/01/2024 | Q2 2024 | $4.07 | $4.01 | -0.06 | $2.39 B | $2.46 B |
| 04/24/2024 | Q1 2024 | $3.47 | $2.71 | -0.76 | $2.31 B | $2.29 B |
| 02/13/2024 | Q4 2023 | N/A | $1.72 | N/A | $2.47 B | $2.39 B |
| 11/08/2023 | Q3 2023 | $3.99 | -$0.47 | -4.46 | $2.40 B | $2.53 B |
| 07/25/2023 | Q2 2023 | $3.77 | $4.09 | 0.32 | $2.37 B | $2.46 B |
| 04/25/2023 | Q1 2023 | $3.28 | $2.69 | -0.59 | $2.34 B | $2.46 B |
| 02/15/2023 | Q4 2022 | $3.48 | $3.82 | 0.34 | $2.45 B | $2.54 B |
| 10/25/2022 | Q3 2022 | $4.13 | $7.86 | 3.73 | $2.47 B | $2.51 B |
| 07/20/2022 | Q2 2022 | $4.06 | $7.25 | 3.19 | $2.47 B | $2.59 B |
| 05/03/2022 | Q1 2022 | $4.41 | $2.06 | -2.35 | $2.50 B | $2.53 B |
| 02/03/2022 | Q4 2021 | $3.32 | $2.51 | -0.81 | $2.62 B | $2.73 B |
| 10/20/2021 | Q3 2021 | $4.15 | $2.22 | -1.93 | $2.67 B | $2.78 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Biogen Inc Earnings: FAQ's
In the previous quarter, Biogen Inc (:BIIB) reported $3.6 earnings per share (EPS) to beat the analysts' consensus estimate of $2.94 by $0.66.
The conference call for Biogen Inc's latest earnings report can be listened to online.
The conference call transcript for Biogen Inc's latest earnings report can be read online.
Biogen Inc (:BIIB) has a recorded annual revenue of $9.81 B.
Biogen Inc (:BIIB) has a recorded net income of $1.29 B.Biogen Inc has generated $8.85 earnings per share over the last four quarters.
Biogen Inc (:BIIB) has a price-to-earnings ratio of 38.17 and price/earnings-to-growth ratio is -0.83.